AI-powered drug discovery: update (X)
β΄οΈ Talem Therapeutics, β³οΈ Xyphos Biosciences, π Genesis Therapeutics, π· Ribometrix, πΆ Astrogen, βοΈ Iktos, π Nuntius Therapeutics, π° AIRNA and β Generate Biomedicines
βLeadership is not domination, but the art of persuading people to work toward a common goal.β
Daniel Goleman, Emotional Intelligence
For the previous newsletters of this series of updates specifically on AI drug discovery companies with assets in preclinical and clinical trials π


